Skip to content

Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures

Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures: a Multicenter Prospective Cohort Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06379243
Enrollment
560
Registered
2024-04-23
Start date
2023-12-01
Completion date
2027-12-31
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compression Fracture, Osteoporosis Fracture, Osteoporosis Vertebral, Perform PVP / PKP Treatment

Keywords

osteoporosis, spinal vertebral fractures, PVP / PKP treatment

Brief summary

In this project, IDEAL-IQ technology and PDFF and R2\* image-based imaging methods are used to analyze the intrinsic relationship between preoperative vertebral bone marrow fat content, magnetic susceptibility properties of bone tissue and bone strength (bone volume and bone mass), to explore the mechanism of vertebral re-fracture after PVP / PKP, and to explore the imaging markers for the risk of postoperative vertebral re-fracture after PVP / PKP. To construct a precise and individualized risk assessment model of vertebral re-fracture after PVP/ PKP by combining clinical risk factors, preoperative quantitative MRI parameters (PDFF, R2\*) and imaging characteristics, so as to achieve the goal of objectively and accurately evaluating the risk of vertebral re-fracture at the early stage of the postoperative period (1 year).

Interventions

PROCEDUREPVP/PKP

PVP or PKP surgery in patients with osteoporotic vertebral compression fractures

Sponsors

Guangzhou Medical University
CollaboratorOTHER
Huizhou Municipal Central Hospital
CollaboratorOTHER
Dongguan Hospital of Traditional Chinese Medicine
CollaboratorOTHER
The Seventh Affiliated Hospital of Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with osteoporotic vertebral fractures of the thoracic and lumbar level with reference to the 2022 edition of the Osteoporotic Fractures Guidelines (2022 edition); * The presence of bone marrow edema or hemorrhage (acute fracture) in the fractured vertebrae is clearly defined by MR examination, and the responsible vertebrae is treated with PVP / PKP; * Number of fractured vertebrae: 1-3 vertebral compression fractures (including old fractures).

Exclusion criteria

* History of severe scoliosis, vertebroplasty, or internal spinal fixation; * Presence of spinal infection and malignant neoplastic disease; * Presence of mental disease, cognitive impairment, or critical illness (e.g., severe cardiac or cerebrovascular disease).

Design outcomes

Primary

MeasureTime frameDescription
Non-operative vertebral re-fracture within 1 year after PVP / PKP1 yearNon-operative vertebral re-fracture within 1 year after PVP / PKP, confirmed by follow-up spinal MRI

Secondary

MeasureTime frameDescription
Visual Analog Score (VAS) at 1 year after PVP/ PKP1 yearVisual Analog Score (VAS) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review.
Oswestry Dysfunction Index (ODI) at 1 year after PVP/PKP1 yearOswestry Dysfunction Index (ODI) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review.

Countries

China

Contacts

Primary Contactjinhui cai
caijinhui123456@163.com+86 18002299663

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026